Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017-Reference-Cited by-同舟云学术

Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017

Published:2019-12-18 Issue:12 Volume:2 Page:e1917669
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Powis Kathleen M.¹²³,Huo Yanling⁴,Williams Paige L.⁴⁵⁶,Kacanek Deborah⁴,Jao Jennifer⁷⁸,Patel Kunjal⁴⁵,Seage George R.⁵,Van Dyke Russell B.⁹,Chadwick Ellen G.⁷⁸,

Affiliation:

1. Department of Internal Medicine, Massachusetts General Hospital, Boston

2. Department of Pediatrics, Massachusetts General Hospital, Boston

3. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

4. Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

6. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

7. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

8. Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois

9. Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2757628/powis_2019_oi_190670.pdf

Reference20 articles.

1. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.;Centers for Disease Control and Prevention;MMWR Recomm Rep,1994

2. Reduction of maternal–infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.;Connor;N Engl J Med,1994

3. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States.;Centers for Disease Control and Prevention;MMWR Recomm Rep,1998

4. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.;Griner;AIDS Patient Care STDS,2011

5. Trends in antiretroviral drug use during pregnancy among HIV-infected women on Medicaid: 2000-2007.;Phiri;AIDS Patient Care STDS,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone;Frontiers in Molecular Neuroscience;2024-04-05

2. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children;AIDS Patient Care and STDs;2023-03-01

3. Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study;HIV Medicine;2022-06-14

4. HIV-Positive and HIV-Negative Women with Medicaid Have Similar Rates of Stillbirth and Preterm Birth;Women's Health Reports;2022-01-01

5. Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development;Frontiers in Pediatrics;2021-10-13